191 related articles for article (PubMed ID: 34370182)
1. In-depth characterization of a new patient-derived xenograft model for metaplastic breast carcinoma to identify viable biologic targets and patterns of matrix evolution within rare tumor types.
Matossian MD; Chang T; Wright MK; Burks HE; Elliott S; Sabol RA; Wathieu H; Windsor GO; Alzoubi MS; King CT; Bursavich JB; Ham AM; Savoie JJ; Nguyen K; Baddoo M; Flemington E; Sirenko O; Cromwell EF; Hebert KL; Lau F; Izadpanah R; Brown H; Sinha S; Zabaleta J; Riker AI; Moroz K; Miele L; Zea AH; Ochoa A; Bunnell BA; Collins-Burow BM; Martin EC; Burow ME
Clin Transl Oncol; 2022 Jan; 24(1):127-144. PubMed ID: 34370182
[TBL] [Abstract][Full Text] [Related]
2. Drug resistance profiling of a new triple negative breast cancer patient-derived xenograft model.
Matossian MD; Burks HE; Elliott S; Hoang VT; Bowles AC; Sabol RA; Wahba B; Anbalagan M; Rowan B; Abazeed ME; Bunnell BA; Moroz K; Miele L; Rhodes LV; Jones SD; Martin EC; Collins-Burow BM; Burow ME
BMC Cancer; 2019 Mar; 19(1):205. PubMed ID: 30845999
[TBL] [Abstract][Full Text] [Related]
3. A novel patient-derived xenograft model for claudin-low triple-negative breast cancer.
Matossian MD; Burks HE; Bowles AC; Elliott S; Hoang VT; Sabol RA; Pashos NC; O'Donnell B; Miller KS; Wahba BM; Bunnell BA; Moroz K; Zea AH; Jones SD; Ochoa AC; Al-Khami AA; Hossain F; Riker AI; Rhodes LV; Martin EC; Miele L; Burow ME; Collins-Burow BM
Breast Cancer Res Treat; 2018 Jun; 169(2):381-390. PubMed ID: 29392581
[TBL] [Abstract][Full Text] [Related]
4. Combination of PI3K and MEK inhibitors yields durable remission in PDX models of PIK3CA-mutated metaplastic breast cancers.
Coussy F; El Botty R; Lavigne M; Gu C; Fuhrmann L; Briaux A; de Koning L; Dahmani A; Montaudon E; Morisset L; Huguet L; Sourd L; Painsec P; Chateau-Joubert S; Larcher T; Vacher S; Melaabi S; Salomon AV; Marangoni E; Bieche I
J Hematol Oncol; 2020 Feb; 13(1):13. PubMed ID: 32087759
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of FGFR targeting in breast cancer through interrogation of patient-derived models.
Chew NJ; Lim Kam Sian TCC; Nguyen EV; Shin SY; Yang J; Hui MN; Deng N; McLean CA; Welm AL; Lim E; Gregory P; Nottle T; Lang T; Vereker M; Richardson G; Kerr G; Micati D; Jardé T; Abud HE; Lee RS; Swarbrick A; Daly RJ
Breast Cancer Res; 2021 Aug; 23(1):82. PubMed ID: 34344433
[TBL] [Abstract][Full Text] [Related]
6. Multifunctional profiling of triple-negative breast cancer patient-derived tumoroids for disease modeling.
Cromwell EF; Sirenko O; Nikolov E; Hammer M; Brock CK; Matossian MD; Alzoubi MS; Collins-Burow BM; Burow ME
SLAS Discov; 2022 Apr; 27(3):191-200. PubMed ID: 35124274
[TBL] [Abstract][Full Text] [Related]
7. Development of Patient Derived Xenograft Models of Overt Spontaneous Breast Cancer Metastasis: A Cautionary Note.
Paez-Ribes M; Man S; Xu P; Kerbel RS
PLoS One; 2016; 11(6):e0158034. PubMed ID: 27355476
[TBL] [Abstract][Full Text] [Related]
8. Establishment of chemosensitivity tests in triple-negative and BRCA-mutated breast cancer patient-derived xenograft models.
Park HS; Lee JD; Kim JY; Park S; Kim JH; Han HJ; Choi YA; Choi AR; Sohn JH; Kim SI
PLoS One; 2019; 14(12):e0225082. PubMed ID: 31821346
[TBL] [Abstract][Full Text] [Related]
9. Leptin produced by obesity-altered adipose stem cells promotes metastasis but not tumorigenesis of triple-negative breast cancer in orthotopic xenograft and patient-derived xenograft models.
Sabol RA; Bowles AC; Côté A; Wise R; O'Donnell B; Matossian MD; Hossain FM; Burks HE; Del Valle L; Miele L; Collins-Burow BM; Burow ME; Bunnell BA
Breast Cancer Res; 2019 May; 21(1):67. PubMed ID: 31118047
[TBL] [Abstract][Full Text] [Related]
10. Functional characterization of androgen receptor in two patient-derived xenograft models of triple negative breast cancer.
Wang X; Petrossian K; Huang MJ; Saeki K; Kanaya N; Chang G; Somlo G; Chen S
J Steroid Biochem Mol Biol; 2021 Feb; 206():105791. PubMed ID: 33271252
[TBL] [Abstract][Full Text] [Related]
11. Pharmacologic profiling of patient-derived xenograft models of primary treatment-naïve triple-negative breast cancer.
Powell RT; Redwood A; Liu X; Guo L; Cai S; Zhou X; Tu Y; Zhang X; Qi Y; Jiang Y; Echeverria G; Feng N; Ma X; Giuliani V; Marszalek JR; Heffernan TP; Vellano CP; White JB; Stephan C; Davies PJ; Moulder S; Symmans WF; Chang JT; Piwnica-Worms H
Sci Rep; 2020 Oct; 10(1):17899. PubMed ID: 33087803
[TBL] [Abstract][Full Text] [Related]
12. A Case of Rare Matrix-producing Triple-negative Breast Carcinoma for Which Drug Response in a Patient-derived Orthotopic Xenograft Mouse Model Was Correlated With Patient Response.
Nomura T; Kurebayashi J; Moriya T; Saito W; Murata T; Yamamoto J; Hozumi C; Hoffman RM
Anticancer Res; 2021 Dec; 41(12):6191-6197. PubMed ID: 34848473
[TBL] [Abstract][Full Text] [Related]
13. Characterizing the efficacy of cancer therapeutics in patient-derived xenograft models of metastatic breast cancer.
Turner TH; Alzubi MA; Sohal SS; Olex AL; Dozmorov MG; Harrell JC
Breast Cancer Res Treat; 2018 Jul; 170(2):221-234. PubMed ID: 29532339
[TBL] [Abstract][Full Text] [Related]
14. A Population of Heterogeneous Breast Cancer Patient-Derived Xenografts Demonstrate Broad Activity of PARP Inhibitor in BRCA1/2 Wild-Type Tumors.
Evans KW; Yuca E; Akcakanat A; Scott SM; Arango NP; Zheng X; Chen K; Tapia C; Tarco E; Eterovic AK; Black DM; Litton JK; Yap TA; Tripathy D; Mills GB; Meric-Bernstam F
Clin Cancer Res; 2017 Nov; 23(21):6468-6477. PubMed ID: 29093017
[No Abstract] [Full Text] [Related]
15. Eribulin Regresses a Cisplatinum-resistant Rare-type Triple-negative Matrix-producing Breast Carcinoma Patient-derived Orthotopic Xenograft Mouse Model.
Yamamoto J; Murata T; Sugisawa N; Higuchi T; Tashiro Y; Nishino H; Inubushi S; Sun YU; Lim H; Miyake K; Shimoya K; Nomura T; Kurebayashi J; Tanino H; Hozumi C; Bouvet M; Singh SR; Endo I; Hoffman RM
Anticancer Res; 2020 May; 40(5):2475-2479. PubMed ID: 32366391
[TBL] [Abstract][Full Text] [Related]
16. Patient-derived xenografts of triple-negative breast cancer reproduce molecular features of patient tumors and respond to mTOR inhibition.
Zhang H; Cohen AL; Krishnakumar S; Wapnir IL; Veeriah S; Deng G; Coram MA; Piskun CM; Longacre TA; Herrler M; Frimannsson DO; Telli ML; Dirbas FM; Matin AC; Dairkee SH; Larijani B; Glinsky GV; Bild AH; Jeffrey SS
Breast Cancer Res; 2014 Apr; 16(2):R36. PubMed ID: 24708766
[TBL] [Abstract][Full Text] [Related]
17. The small G-protein RalA promotes progression and metastasis of triple-negative breast cancer.
Thies KA; Cole MW; Schafer RE; Spehar JM; Richardson DS; Steck SA; Das M; Lian AW; Ray A; Shakya R; Knoblaugh SE; Timmers CD; Ostrowski MC; Chakravarti A; Sizemore GM; Sizemore ST
Breast Cancer Res; 2021 Jun; 23(1):65. PubMed ID: 34118960
[TBL] [Abstract][Full Text] [Related]
18. Establishing and characterizing patient-derived xenografts using pre-chemotherapy percutaneous biopsy and post-chemotherapy surgical samples from a prospective neoadjuvant breast cancer study.
Yu J; Qin B; Moyer AM; Sinnwell JP; Thompson KJ; Copland JA; Marlow LA; Miller JL; Yin P; Gao B; Minter-Dykhouse K; Tang X; McLaughlin SA; Moreno-Aspitia A; Schweitzer A; Lu Y; Hubbard J; Northfelt DW; Gray RJ; Hunt K; Conners AL; Suman VJ; Kalari KR; Ingle JN; Lou Z; Visscher DW; Weinshilboum R; Boughey JC; Goetz MP; Wang L
Breast Cancer Res; 2017 Dec; 19(1):130. PubMed ID: 29212525
[TBL] [Abstract][Full Text] [Related]
19. Development and characterization of patient-derived xenografts from non-small cell lung cancer brain metastases.
Baschnagel AM; Kaushik S; Durmaz A; Goldstein S; Ong IM; Abel L; Clark PA; Gurel Z; Leal T; Buehler D; Iyer G; Scott JG; Kimple RJ
Sci Rep; 2021 Jan; 11(1):2520. PubMed ID: 33510214
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of deacetylase inhibition in metaplastic breast carcinoma using multiple derivations of preclinical models of a new patient-derived tumor.
Chang TC; Matossian MD; Elliott S; Burks HE; Sabol RA; Ucar DA; Wathieu H; Zabaleta J; Del Valle L; Gill S; Martin E; Riker AI; Miele L; Bunnell BA; Burow ME; Collins-Burow BM
PLoS One; 2020; 15(10):e0226464. PubMed ID: 33035223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
